LATE-BREAKING ABSTRACT: The effect of route of presentation on lung cancer outcome

L. Succony, E. Swanson, S. Gauntett, J. Ramsay (Luton, United Kingdom)

Source: Annual Congress 2012 - Early detection of lung cancer
Session: Early detection of lung cancer
Session type: Oral Presentation
Number: 1637

Congress or journal article abstractSlide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L. Succony, E. Swanson, S. Gauntett, J. Ramsay (Luton, United Kingdom). LATE-BREAKING ABSTRACT: The effect of route of presentation on lung cancer outcome. Eur Respir J 2012; 40: Suppl. 56, 1637

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: The impact of desensitization therapy prior to lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012


LATE-BREAKING ABSTRACT: The role of eosinophils in Kras-G12D induced lung tumor initiation and progression
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

LATE-BREAKING ABSTRACT: On the effectiveness of steroids in acute lung injury: Experimental separation between inflammation and hypoxemia
Source: Annual Congress 2012 - Novel mechanisms of acute lung injury
Year: 2012

Brain metastasis as initial presentation of lung cancer - Impact of prognostic factors on patient survival
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

LATE-BREAKING ABSTRACT: The effect of beta2-agonist on lung clearance index in COPD patients
Source: International Congress 2015 – Lung function: new findings and approaches
Year: 2015

The impact of HIV infection on the presentation and prognosis of lung cancer
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


LATE-BREAKING ABSTRACT: 17q21 variants modify the effect of early viral infections on childhood asthma
Source: Annual Congress 2009 - Environmental and genetic risk factors for asthma and COPD
Year: 2009

LATE-BREAKING ABSTRACT: Amelioration of hyperoxia-induced lung injury in newborn mice using a sphingolipid-based intervention
Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond
Year: 2012

LATE-BREAKING ABSTRACT: Interval lung cancers not detected on screening chest x-rays: How are they different?
Source: Annual Congress 2012 - Early detection of lung cancer
Year: 2012



LATE-BREAKING ABSTRACT: The RENEW trial: Predictors of effectiveness of endobronchial coil therapy in patients with advanced emphysema
Source: International Congress 2016 – Airway stenting and ablation
Year: 2016

LATE-BREAKING ABSTRACT: The role of modification of CURB-65 score as prediction factor for one year survival in acute exacerbation of COPD
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012


Does age have an effect on the symptoms and signs of lung cancer?
Source: Eur Respir J 2001; 18: Suppl. 33, 64s
Year: 2001

Survival outcomes of non small cell lung cancer (NSCLC) patients who are suitable for radical treatment at initial presentation
Source: Annual Congress 2011 - Quality management for lung cancer patients
Year: 2011


LATE-BREAKING ABSTRACT: Acute impact of a single e-cigarette smoking on symptoms, vital signs and airway inflammatory response
Source: Annual Congress 2012 - Tobacco and shisha exposure in children and adolescents
Year: 2012


Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013



LATE-BREAKING ABSTRACT: Early relapse of non-small cell lung cancer (NSCLC) found after CNS-symptoms
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Analysis of clinical factors in relationship to treatment effects of erlotinib in non small cell lung cancer (NSCLC) patients
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


LATE-BREAKING ABSTRACT: Expression of macrophage migration inhibitory factor (MIF) in the serum and lung tissues in patients with non-small cell lung cancer (NSCLC)
Source: Annual Congress 2012 - Prognosis of lung cancer
Year: 2012

Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003


LATE-BREAKING ABSTRACT: DS102: A bioactive lipid for the treatment of chronic pulmonary disorders
Source: International Congress 2016 – Novel mechanisms and therapeutic targets in acute and chronic inflammatory disease
Year: 2016